Privileged substructures are of potentially great importance in medicinal chemistry. These scaffolds are characterized by their ability to promiscuously bind to a multitude of receptors through a variety of favorable characteristics. This may include presentation of their substituents in a spatially defined manner and perhaps also the ability to directly bind to the receptor itself, as well as exhibiting promising characteristics to aid bioavailability of the overall molecule. It is believed that some privileged substructures achieve this through the mimicry of common protein surface elements that are responsible for binding, such as β- and gamma;-turns. As a result, these structures represent a promising means by which new lead compounds may be identified.

The combinatorial synthesis of bicyclic privileged structures or privileged substructures

The biochemistry and medical significance of the flavonoids.

Recent Developments in Ring Opening Polymerization of Lactones for Biomedical Applications

Polycaprolactone (PCL) is an important polymer due to its mechanical properties, miscibility with a large range of other polymers and biodegradability. Two main pathways to produce polycaprolactone have been described in the literature: the polycondensation of a hydroxycarboxylic acid: 6-hydroxyhexanoic acid, and the ring-opening polymerisation (ROP) of a lactone: e-caprolactone (e-CL). This critical review summarises the different conditions which have been described to synthesise PCL, and gives a broad overview of the different catalytic systems that were used (enzymatic, organic and metal catalyst systems). A surprising variety of catalytic systems have been studied, touching on virtually every section of the periodic table. A detailed list of reaction conditions and catalysts/initiators is given and reaction mechanisms are presented where known. Emphasis is put on the ROP pathway due to its prevalence in the literature and the superior polymer that is obtained. In addition, ineffective systems that have been tried to catalyse the production of PCL are included in the electronic supplementary information for completeness (141 references).

/pdf/synthesis-of-polycaprolactone-a-review-vlm9rxg878.pdf

Synthesis of polycaprolactone: a review

Biodegradable synthetic polymers: Preparation, functionalization and biomedical application

The yeast lipase Candida cylindracea (CCL) and porcine pancreatic lipase (PPL) have been used for regioselective deacylation of peracetylated benzopyrones, diphenylpropenones and acetophenones for the first time. The deacylation study on different classes of polyphenols has revealed that the presence of carbonyl group attached to the aromatic ring is needed by the lipases to exhibit regioselectivity towards hydrolysis of acetoxyl groups. The acetoxyl groups at positions other than the one at ortho position to the carbonyl group get selectively hydrolysed by PPL in orgnnic solvents. The trnnsesterification reactions using triflouroethylbutyrate (TFEB), catalysed by PPL and CCL on some polyols in dry organic solvents were also performed. It was found that the primary hydroxyl is acylated. In D-panthenol, the oxidised dextrorotatory form of which is a major constituent of vitamin B-complex, the primary hydroxyl group at the far end of the asymmetric carbon atom gets exclusively acylated. This work should be of importance in the synthesis of building blocks of biologically active natural products which may provide structural leads to anti AIDS and anticancer agents.

Potential applications of enzyme-mediated transesterifications in the synthesis of bioactive compounds

/pdf/crystal-structure-of-potassium-pentavanadate-3neic91o9g.pdf

Kirpal S. Bisht

Papers

Potential applications of enzyme-mediated transesterifications in the synthesis of bioactive compounds

Crystal structure of potassium pentavanadate

Spatially directional multiarm poly(ε-caprolactone) based on resorcin[4]arene cavitand core

A wax ester from Piper clarkii

Protein kinase C δ (PKCδ) splice variants modulate apoptosis pathway in 3T3L1 cells during adipogenesis: identification of PKCδII inhibitor.